Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
SSE:688621.SS
54.23 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 169.013 | 182.895 | 158.04 | 108.792 | 74.163 | 47.933 | 20.161 | 1.121 |
| Depreciation & Amortization
| 50.023 | 44.929 | 39.979 | 28.473 | 10.452 | 7.787 | 5.324 | 2.25 |
| Deferred Income Tax
| 0 | -22.131 | -11.047 | -2.379 | -0.325 | 0.356 | -0.635 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -280.988 | -225.739 | -131.617 | -65.225 | -29.352 | -0.369 | 11.137 | 1.708 |
| Accounts Receivables
| -326.366 | -250.51 | -151.922 | -143.037 | -35.125 | -30.012 | -35.35 | 0 |
| Inventory
| -0.637 | -1.872 | -4.696 | -1.552 | -2.548 | 0.152 | -2.402 | -1.242 |
| Accounts Payables
| 0 | 48.774 | 36.048 | 81.742 | 8.647 | 29.135 | 49.524 | 0 |
| Other Working Capital
| 46.015 | -22.131 | -11.047 | -2.379 | -0.325 | 0.356 | 13.539 | 2.951 |
| Other Non Cash Items
| 93.971 | 112.907 | 37.558 | 16.211 | 7.732 | 1.621 | 7.487 | 2.932 |
| Operating Cash Flow
| 32.019 | 92.861 | 103.959 | 88.25 | 62.995 | 56.973 | 44.109 | 8.012 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -30.483 | -72.959 | -103.868 | -84.957 | -27.033 | -25.671 | -16.411 | -20.956 |
| Acquisitions Net
| 0 | 0 | 1.75 | 84.958 | -3.995 | 0 | 9.939 | 0 |
| Purchases Of Investments
| -190 | -20 | -85.75 | -495 | -79.09 | -20 | 0 | -0.07 |
| Sales Maturities Of Investments
| 152.855 | 4.291 | 178.117 | 304.173 | 74.417 | 20.364 | 1.071 | 0 |
| Other Investing Activites
| 25 | 0.004 | -1.75 | -84.957 | 0 | 10.148 | 35.614 | -11.65 |
| Investing Cash Flow
| -42.628 | -88.665 | -11.5 | -275.782 | -35.702 | -15.159 | 20.274 | -32.675 |
| Financing Activities: | ||||||||
| Debt Repayment
| 12.424 | 181.959 | 63.167 | -16.188 | -1.504 | -5.72 | -20 | 20 |
| Common Stock Issued
| 0 | 0 | 0 | -16.896 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 16.896 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -38.154 | -55.516 | -21.2 | -1.248 | -1.071 | -0.306 | -1.06 | -0.508 |
| Other Financing Activities
| -102.007 | -48.638 | -15.748 | 602.809 | 8.098 | 9 | -17.241 | 1.632 |
| Financing Cash Flow
| -127.737 | 77.805 | 26.219 | 568.478 | 5.523 | 2.974 | -38.301 | 21.125 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Net Change In Cash
| -138.346 | 82.002 | 118.678 | 380.946 | 32.816 | 44.787 | 26.082 | -3.539 |
| Cash At End Of Period
| 552.585 | 690.931 | 608.93 | 490.251 | 109.305 | 76.489 | 31.702 | 5.62 |